chronic

(redirected from chronic obstructive pulmonary disease)
Also found in: Dictionary, Thesaurus, Medical, Acronyms, Encyclopedia, Wikipedia.
Related to chronic obstructive pulmonary disease: chronic bronchitis, asthma, COPD, emphysema
References in periodicals archive ?
Vitamin E and vitamin C supplementation in patients with chronic obstructive pulmonary disease.
A review of the Chronic Obstructive Pulmonary Disease (COPD) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
Effect of QVA149 on Exercise Tolerance in Patients With Chronic Obstructive Pulmonary Disease (COPD)(BRIGHT).
1] decline over a 5-year period in mild to moderate chronic obstructive pulmonary disease patients who either received the inhaled corticosteroid, triamcinolone, or placebo.
The mission of the COPD Foundation is to develop and support programs, which improve the quality of life through research, education, early diagnosis, and enhanced therapy for persons whose lives are impacted by Chronic Obstructive Pulmonary Disease.
Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Chronic Obstructive Pulmonary Disease (COPD) Therapeutics market revenues data from 2005 to 2009, forecast for eight years to 2017.
As time goes on, people with chronic obstructive pulmonary disease may experience breathlessness when walking even a short distance.
Gain insight into market potential, including a robust 10-year epidemiology forecast of chronic obstructive pulmonary disease prevalent cases.
Coverage of the Chronic Obstructive Pulmonary Disease (COPD) pipeline on the basis of therapeutic class, route of administration and molecule type.
COPD: Journal of Chronic Obstructive Pulmonary Disease, which offers an in-depth and easy-to-access array of research findings in this field, is an ideal partner for the Foundation.
Chronic Obstructive Pulmonary Disease (COPD) - Drug Pipeline Analysis and Market Forecasts to 2016 which provides the key data, information and analysis on the COPD market.
The Company manages major chronic diseases and episodic conditions including diabetes, congestive heart failure, coronary artery disease, asthma, chronic obstructive pulmonary disease, high-risk obstetrics, cancer, musculoskeletal and chronic pain, depression, obesity, and other conditions.

Full browser ?